To be more specific, depletion of Pcif1 in CRC cells enhanced the effects of anti‐PD‐1 treatment in immunocompetent mice by increasing IFN-γ, TNF-α, and decreasing TGF-β levels, which recruited tumor‐infiltrating natural killer cells in TME (35). The gene discussed is PDCD1; the disease is neoplasm.